The efficacy and safety of intraocular anti-VEGF injections versus anti-VEGF combined with steroids or steroid monotherapy for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Front Med (Lausanne)Cai H, Tian M, Huang Z, Wang B.
europepmc +1 more source
Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk. [PDF]
Int J Retina VitreousAntonietti M +3 more
europepmc +1 more source
Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study. [PDF]
Int J Retina VitreousLombardo M +6 more
europepmc +1 more source
Efficacy and safety of different anti-VEGF agents combined with pars plana vitrectomy in proliferative diabetic retinopathy: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Front Endocrinol (Lausanne)Lu S, Lin Y, Lin L, Chen S.
europepmc +1 more source
Unexplained long-term increase in intraocular pressure during the treatment of macular disease with intravitreal anti-VEGF. [PDF]
Graefes Arch Clin Exp OphthalmolEisenrauch LM +5 more
europepmc +1 more source
Related searches:
Ranibizumab is the antigen-binding fragment of a recombinant, humanised monoclonal antibody, which binds with high affinity to, and inhibits the activity of, all active forms of vascular endothelial growth factor A, an important mediator in the development of choroidal neovascularisation.
Stephanie K A, Blick +2 more
+5 more sources